Protagonist Therapeutics أخبار Eulerpool

أخبار سهم Protagonist Therapeutics

يتابع Protagonist Therapeutics العديد من الصحفيين والمستثمرين حول العالم. نقدم هنا أحدث أخبار Protagonist Therapeutics.

• ١٣ نوفمبر ·

  Yahoo
  Protagonist Therapeutics (PTGX) Upgraded to Buy: Here's What You Should Know
• ٧ نوفمبر ·

  Yahoo
  Protagonist Therapeutics (PTGX) Reports Q3 Loss, Tops Revenue Estimates
• ٧ نوفمبر ·

  Yahoo
  Protagonist Therapeutics: Q3 Earnings Snapshot
• ٧ نوفمبر ·

  Yahoo
  Protagonist Reports Third Quarter 2024 Financial Results and Provides Corporate Update
• ٥ نوفمبر ·

  Yahoo
  Protagonist Therapeutics Announces Poster Presentation on Final REVIVE Phase 2 Study Data with Rusfertide at the 66th Annual ASH Meeting
• ٢٩ أكتوبر ·

  Accesswire
  Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million
• ١٨ أكتوبر ·

  Yahoo
  Protagonist Therapeutics Inc. (PTGX): Advancing Treatments for Autoimmune Diseases
• ١٦ أكتوبر ·

  Yahoo
  State Street Corp's Strategic Acquisition in Protagonist Therapeutics Inc
• ١٦ أكتوبر ·

  SeekingAlpha
  The Prognosis For Protagonist Therapeutics: Solid Prospects, But Stock Is Pricey
• ١٤ أكتوبر ·

  TipRanks
  TD Cowen Keeps Their Buy Rating on Protagonist Therapeutics (PTGX)